Scholar Rock Pipeline

Our pipeline of innovative new medicines adresses serious diseases with high unmet medical need, including neuromuscular disease, cancer and fibrosis. By modulating the fundamental mechanism of supracellular activation, our medicines are designed to specifically act at the source of disease in the microenvironment to realize the potential of targeting growth factors.

 

All of Scholar Rock’s drug candidates are investigational. Their effectiveness and safety have not been established, nor have they been approved by the FDA or any other regulatory agency.
CONTACT  |  SITEMAP  | 
 |  SITE DESIGN
“Scholar Rock” is a registered trademark of Scholar Rock, Inc.  |  © 2017 Scholar Rock All Rights Reserved.
Back to Top
 

The site you are about to visit is maintained by another organization, which is solely responsible for its content. As we cannot control the content or privacy practices of any third-party websites, we encourage you to read the privacy policy of every website you visit.

Continue   Cancel